Find out more about the start-ups mentored
HifiBio Therapeutics
Launched in 2014 by Medalis, HiFiBiO Therapeutics develops new therapeutic antibodies to combat cancer, auto-immune and infectious diseases.
Learn more...Inoviem scientific
Inoviem Scientific was the first company mentored by Medalis in 2011, it performs innovative pre-clinical analyses to accelerate the development of new drugs and facilitate the emergence of personalised medicine.
Learn more...Syndivia
Syndivia develops new anti-cancer treatments by exploiting the unique properties of cancerous cells and their microenvironment.
Learn more...Peptimimesis
PeptiMimesis is a strategic partner in the design, discovery and early development of therapeutic transmembrane peptides.
Learn more...Adaptherapy
ADAPTHERAPY® develops solutions aiming to help clinicians to select the most appropriate therapy for each patient with cancer or other complex diseases.
Learn more...Biodol
Biodol develops a therapeutic solution to treat neuropathic pain, a chronic disease that affects 7 to 10% of the population in France.
Learn more...MicroOmix
MicroOmiX develops a “single cell” analysis technology based on droplet microfluidics and an ultrasensitive proprietary system to detect secreted molecules.
Learn more...